<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00311974</url>
  </required_header>
  <id_info>
    <org_study_id>MED.RES.HOS.2006.01.HV</org_study_id>
    <secondary_id>99127500</secondary_id>
    <nct_id>NCT00311974</nct_id>
  </id_info>
  <brief_title>The Effect of Dihydralazine on Kidney Function and Hormones in Healthy Individuals</brief_title>
  <official_title>The Effect of Dihydralazine on Renal Tubular Function and Vasoactive Hormones in Healthy Individuals</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Regional Hospital Holstebro</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Regional Hospital Holstebro</source>
  <brief_summary>
    <textblock>
      We, the investigators at Holstebro Hospital, want to test the hypothesis that dihydralazine
      leads to the activation of the sympathetic nervous system in healthy individuals.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2006</start_date>
  <completion_date type="Actual">November 2007</completion_date>
  <primary_completion_date type="Actual">November 2007</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fractional sodium excretion</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Heart rate</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Blood pressure</measure>
  </primary_outcome>
  <enrollment>16</enrollment>
  <condition>Healthy</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dihydralazine</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Men

          2. Ages 18 to 40 years.

          3. Body mass index less than or equal to 30 kg/m2

        Exclusion Criteria:

          1. History or clinical signs of heart, lung, kidney, or endocrine organ disease.

          2. Abnormal biochemical screening of the blood regarding: B-hemoglobin, P-sodium,
             P-potassium, P-creatinine, P-albumin, P-bilirubin, P-alanine aminotransferase,
             P-alkaline phosphatase, P-cholesterol, and B-glucose.

          3. Abnormal screening of the urine regarding: albumin and glucose

          4. Malignant disease.

          5. Known arterial hypertension or measured 24 hour blood pressure above 135 mmHg systolic
             or 85 mmHg diastolic.

          6. Alcohol abuse.

          7. Smoking.

          8. Drug use or abuse.

          9. Known intolerance or allergy to dihydralazine

         10. Blood donation within 1 month of the start of the study.
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Erling B Pedersen, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>Department of Medical Research, Holstebro Hospital, Denmark</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Henrik Vase, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Medical Research, Holstebro Hospital, Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Medical Research, Holstebro Hospital</name>
      <address>
        <city>Holstebro</city>
        <zip>7500</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>February 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 5, 2006</study_first_submitted>
  <study_first_submitted_qc>April 5, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 7, 2006</study_first_posted>
  <last_update_submitted>February 17, 2010</last_update_submitted>
  <last_update_submitted_qc>February 17, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 18, 2010</last_update_posted>
  <keyword>Dihydralazine</keyword>
  <keyword>Sympathetic activation</keyword>
  <keyword>Fractional sodium excretion</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hormones</mesh_term>
    <mesh_term>Dihydralazine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

